Diagnostic test cartridges run at production volumes measured in the millions of units per year, where a bonding process that’s 99.5% reliable still means thousands of rejected cartridges every month. At that scale, adhesive selection is as much a manufacturing-economics decision as a technical one.
Why Cartridge Manufacturing Rewards Speed and Inline Inspection
Diagnostic cartridges combine microfluidic channels, sensor components, and a housing shell, often assembled on fully automated lines running continuously. UV-curable adhesives fit this environment well because cure happens in seconds under 365–405 nm exposure, matching automated dispense-and-cure cycle times without requiring an oven stage or extended clamp time that would bottleneck throughput. Just as important at this volume is inline inspectability — a defect rate that would be manageable to catch with manual inspection at low volume becomes a real quality-escape risk at millions of units per year without automated verification built into the process.
Selecting the Right Incure Grade for Cartridge Assembly
For sealing microfluidic channels and small sample-chamber joints, the Incure Cyro-Weld™ 5013 (750–1,500 cP) draws in by capillary action, forming a complete seal along narrow channel walls without adding bulk that could obstruct fluid flow through the cartridge.
For housing and component bonding that needs both high tensile strength and inline verification at automated-line speeds, the Cyro-Weld™ 5002FT is a thixotropic, high-tensile grade (5,500–11,000 cP) that fluoresces under UV black light, letting a vision-inspection system confirm bond coverage on every unit rather than relying on statistical sampling alone — a meaningful advantage when the production volume makes 100% manual inspection impractical.
Housing shells combining rigid polycarbonate with internal sensor or membrane components are a common setting for CTE mismatch causes adhesive bond failure, worth accounting for given the range of storage conditions these cartridges may see before use.
Sterilization, Biocompatibility, and Regulatory Considerations
Both grades are formulated to meet ISO 10993-5 cytotoxicity standards and are validated for Ethylene Oxide (ISO 11135) and Gamma (ISO 11137) sterilization pathways, relevant for cartridges that contact patient sample material even briefly. As with all Incure materials, this reflects formulation-level validated data, not a finished-device clearance — final qualification, including confirming that adhesive cure byproducts don’t interfere with your specific assay chemistry, remains the manufacturer’s responsibility.
Assay interference is worth flagging specifically here, since it’s a consideration unique to diagnostic devices rather than most other bonded medical products — Email Us with your assay chemistry details so our applications team can help assess compatibility before you commit to a bonding process at scale.
Common Failure Modes in High-Volume Cartridge Production
Microfluidic channel obstruction from adhesive migration is a cartridge-specific failure mode not seen in most other bonded devices — excess adhesive wicking beyond the intended bond area can partially block a fluid channel, causing an assay to run incorrectly rather than causing an obvious mechanical defect. Controlling dispense volume precisely, rather than over-applying to guarantee coverage, is the more reliable way to avoid this at scale.
Vision-inspection false negatives are a second consideration specific to high-volume lines: a fluorescing grade like Cyro-Weld™ 5002FT reduces this risk versus a non-fluorescing adhesive, but camera positioning and lighting still need periodic calibration verification, since a drifted camera can pass defective units for an extended run before the drift is caught. Incomplete cure from internal component shadowing is a third pattern, generally resolved by adjusting fixture and light-source geometry rather than extending overall dose time.
FAQ
Q: Can adhesive selection actually affect assay accuracy?
A: Yes, in two ways — physical channel obstruction from adhesive migration, and less commonly, chemical interaction between cured adhesive byproducts and reagents in the assay chemistry, which is why assay-specific compatibility testing matters even when a grade is already biocompatibility-validated in general terms.
Q: How much inspection is realistic at millions of units per year?
A: Automated inline vision inspection on every unit, supplemented by periodic destructive sampling, is generally more practical at this volume than manual inspection of any kind, which is part of why fluorescing adhesive grades that support vision-system verification are worth prioritizing at this scale.
Q: Does dispense volume matter more than adhesive selection for avoiding channel obstruction?
A: Both matter, but dispense-volume control is usually the larger lever — a correctly selected adhesive over-dispensed in volume can still migrate into a channel, while a well-controlled dispense volume of an appropriately viscous grade rarely does, even at high line speed.
Diagnostic cartridge bonding is as much about verified consistency at scale as it is about initial bond strength — a process that performs well in a pilot run of a few hundred units doesn’t automatically hold up across a multi-year production life spanning millions. Our technical team can review your specific cartridge architecture and assay requirements — Contact Our Team for grade recommendations and sample material.
Visit www.incurelab.com for more information.